Skip to main content
. 2021 May 19;12(14):4332–4340. doi: 10.7150/jca.55826

Figure 3.

Figure 3

Prevalence of HR-HPV genotypes based on the histological diagnosis of 902 women with LSIL cytology. (A) Prevalence of HR-HPV genotypes in LSIL patients with biopsy showing normal/CIN1. (B) Prevalence of HR-HPV genotyping models in LSIL patients with biopsy showing normal/CIN1. HPV 16/18: women with HPV 16 and/or HPV 18 infection; HPV 16/18/58: women with any infection of HPV-16, -18, -58; HPV 16/18/52/58: women with any infection of HPV-16, -18, -52, -58; HPV 16/18/33/52/58: women with any infection of HPV-16, -18, -33, -52, -58; HPV 16/18/31/33/52/58: women with any infection of HPV-16, -18, -31, -33, -52, -58. (C) Prevalence of HR-HPV genotypes in LSIL patients with biopsy showing CIN2+. (D) Prevalence of HR-HPV genotyping models in LSIL patients with biopsy showing CIN2+. Abbreviations: HR-HPV, high-risk human papillomavirus; LSIL, low-grade squamous intraepithelial lesion; CIN, cervical intraepithelial neoplasia; CIN2+, cervical intraepithelial neoplasia grade 2 or worse.